Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 560

    1.

    Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study.

    Reardon DA, Desjardins A, Vredenburgh JJ, Gururangan S, Sampson JH, Sathornsumetee S, McLendon RE, Herndon JE 2nd, Marcello JE, Norfleet J, Friedman AH, Bigner DD, Friedman HS.

    Br J Cancer. 2009 Nov 17. [Epub ahead of print]PMID: 19920819 [PubMed - as supplied by publisher]Related articles

    2.

    Does devoutness delay death? Psychological investment in religion and its association with longevity in the Terman sample.

    McCullough ME, Friedman HS, Enders CK, Martin LR.

    J Pers Soc Psychol. 2009 Nov;97(5):866-82.PMID: 19857007 [PubMed - in process]Related articles

    3.

    An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme.

    Sampson JH, Archer GE, Mitchell DA, Heimberger AB, Herndon JE 2nd, Lally-Goss D, McGehee-Norman S, Paolino A, Reardon DA, Friedman AH, Friedman HS, Bigner DD.

    Mol Cancer Ther. 2009 Oct;8(10):2773-9.PMID: 19825799 [PubMed - in process]Related articles

    4.

    Mometasone furoate vs fluticasone propionate with salmeterol: multivariate analysis of resource use and asthma-related charges.

    Navaratnam P, Friedman HS, Urdaneta E.

    Curr Med Res Opin. 2009 Dec;25(12):2895-901.PMID: 19821655 [PubMed - in process]Related articles

    5.

    Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.

    Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T.

    J Clin Oncol. 2009 Oct 1;27(28):4733-40. Epub 2009 Aug 31.PMID: 19720927 [PubMed - indexed for MEDLINE]Related articles

    6.

    A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells.

    Bektas M, Johnson SP, Poe WE, Bigner DD, Friedman HS.

    Cancer Chemother Pharmacol. 2009 Oct;64(5):1053-8. Epub 2009 Jul 12.PMID: 19597728 [PubMed - indexed for MEDLINE]Related articles

    7.

    Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.

    Reardon DA, Desjardins A, Vredenburgh JJ, Gururangan S, Friedman AH, Herndon JE 2nd, Marcello J, Norfleet JA, McLendon RE, Sampson JH, Friedman HS.

    J Neurooncol. 2009 Jun 28. [Epub ahead of print]PMID: 19562254 [PubMed - as supplied by publisher]Related articles

    8.

    Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.

    Friedman HS, Eid NS, Crespi S, Wilcox TK, Reardon G.

    Clin Ther. 2009 May;31(5):1056-63.PMID: 19539106 [PubMed - indexed for MEDLINE]Related articles

    9.

    Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.

    Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Friedman AH, Sampson JH, McLendon RE, Herndon JE 2nd, Friedman HS.

    J Neurooncol. 2009 Dec;95(3):393-400. Epub 2009 Jun 17.PMID: 19533023 [PubMed - in process]Related articles

    10.

    Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy.

    Affronti ML, Heery CR, Herndon JE 2nd, Rich JN, Reardon DA, Desjardins A, Vredenburgh JJ, Friedman AH, Bigner DD, Friedman HS.

    Cancer. 2009 Aug 1;115(15):3501-11.PMID: 19514083 [PubMed - indexed for MEDLINE]Related articles

    11.

    Conscientiousness, career success, and longevity: a lifespan analysis.

    Kern ML, Friedman HS, Martin LR, Reynolds CA, Luong G.

    Ann Behav Med. 2009 Apr;37(2):154-63. Epub 2009 May 20.PMID: 19455378 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Tinzaparin prophylaxis against venous thromboembolic complications in brain tumor patients.

    Perry SL, Bohlin C, Reardon DA, Desjardins A, Friedman AH, Friedman HS, Vredenburgh JJ.

    J Neurooncol. 2009 Oct;95(1):129-34. Epub 2009 May 5.PMID: 19415455 [PubMed - in process]Related articles

    13.

    Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.

    Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Gururangan S, Sampson JH, McLendon RE, Herndon JE 2nd, Friedman HS.

    Cancer. 2009 Jul 1;115(13):2964-70.PMID: 19402172 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Repeatability of quantitative parameters derived from diffusion tensor imaging in patients with glioblastoma multiforme.

    Paldino MJ, Barboriak D, Desjardins A, Friedman HS, Vredenburgh JJ.

    J Magn Reson Imaging. 2009 May;29(5):1199-205.PMID: 19388113 [PubMed - indexed for MEDLINE]Related articles

    15.

    Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma.

    Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Friedman AH, Bigner DD, Sampson JH, McLendon RE, Herndon JE Jr, Walker A, Friedman HS.

    Neuro Oncol. 2009 Oct;11(5):556-61. Epub 2009 Mar 16.PMID: 19289491 [PubMed - indexed for MEDLINE]Related articles

    16.

    Bifunctional DNA alkylator 1,3-bis(2-chloroethyl)-1-nitrosourea activates the ATR-Chk1 pathway independently of the mismatch repair pathway.

    Cui B, Johnson SP, Bullock N, Ali-Osman F, Bigner DD, Friedman HS.

    Mol Pharmacol. 2009 Jun;75(6):1356-63. Epub 2009 Mar 4.PMID: 19261750 [PubMed - indexed for MEDLINE]Related articles

    17.

    Phase I pharmacokinetic study of the vascular endothelial growth factor receptor tyrosine kinase inhibitor vatalanib (PTK787) plus imatinib and hydroxyurea for malignant glioma.

    Reardon DA, Egorin MJ, Desjardins A, Vredenburgh JJ, Beumer JH, Lagattuta TF, Gururangan S, Herndon JE 2nd, Salvado AJ, Friedman HS.

    Cancer. 2009 May 15;115(10):2188-98.PMID: 19248046 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Assessment of physical functioning in recurrent glioma: preliminary comparison of performance status to functional capacity testing.

    Jones LW, Cohen RR, Mabe SK, West MJ, Desjardins A, Vredenburgh JJ, Friedman AH, Reardon DA, Waner E, Friedman HS.

    J Neurooncol. 2009 Aug;94(1):79-85. Epub 2009 Feb 11.PMID: 19212703 [PubMed - indexed for MEDLINE]Related articles

    19.

    Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma.

    Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Friedman AH, Bigner DD, Sampson JH, McLendon RE, Herndon JE 2nd, Walker A, Friedman HS.

    J Clin Oncol. 2009 Mar 10;27(8):1262-7. Epub 2009 Feb 9.PMID: 19204199 [PubMed - indexed for MEDLINE]Related articles

    20.

    Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiforme.

    Quinn JA, Jiang SX, Carter J, Reardon DA, Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Friedman AH, Bigner DD, Sampson JH, McLendon RE, Herndon JE 2nd, Threatt S, Friedman HS.

    Clin Cancer Res. 2009 Feb 1;15(3):1064-8.PMID: 19188181 [PubMed - indexed for MEDLINE]Related articles

    21.

    Genomic and molecular profiling predicts response to temozolomide in melanoma.

    Augustine CK, Yoo JS, Potti A, Yoshimoto Y, Zipfel PA, Friedman HS, Nevins JR, Ali-Osman F, Tyler DS.

    Clin Cancer Res. 2009 Jan 15;15(2):502-10. Erratum in: Clin Cancer Res. 2009 May 1;15(9):3240. PMID: 19147755 [PubMed - indexed for MEDLINE]Related articles

    22.

    Colectomy subtypes, follow-up surgical procedures, postsurgical complications, and medical charges among ulcerative colitis patients with private health insurance in the United States.

    Loftus EV Jr, Friedman HS, Delgado DJ, Sandborn WJ.

    Inflamm Bowel Dis. 2009 Apr;15(4):566-75.PMID: 19143006 [PubMed - indexed for MEDLINE]Related articles

    23.

    Stability of physical activity across the lifespan.

    Friedman HS, Martin LR, Tucker JS, Criqui MH, Kern ML, Reynolds CA.

    J Health Psychol. 2008 Nov;13(8):1092-104.PMID: 18987082 [PubMed - indexed for MEDLINE]Related articles

    24.

    Bevacizumab plus irinotecan in recurrent WHO grade 3 malignant gliomas.

    Desjardins A, Reardon DA, Herndon JE 2nd, Marcello J, Quinn JA, Rich JN, Sathornsumetee S, Gururangan S, Sampson J, Bailey L, Bigner DD, Friedman AH, Friedman HS, Vredenburgh JJ.

    Clin Cancer Res. 2008 Nov 1;14(21):7068-73.PMID: 18981004 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Distress persists in long-term brain tumor survivors with glioblastoma multiforme.

    Keir ST, Farland MM, Lipp ES, Friedman HS.

    J Cancer Surviv. 2008 Dec;2(4):269-74. Epub 2008 Oct 29.PMID: 18958627 [PubMed - indexed for MEDLINE]Related articles

    26.

    Do conscientious individuals live longer? A quantitative review.

    Kern ML, Friedman HS.

    Health Psychol. 2008 Sep;27(5):505-12. Review.PMID: 18823176 [PubMed - indexed for MEDLINE]Related articles

    27.

    Experience with irinotecan for the treatment of malignant glioma.

    Vredenburgh JJ, Desjardins A, Reardon DA, Friedman HS.

    Neuro Oncol. 2009 Feb;11(1):80-91. Epub 2008 Sep 10. Review.PMID: 18784279 [PubMed - indexed for MEDLINE]Related articles

    28.

    Detection of humoral response in patients with glioblastoma receiving EGFRvIII-KLH vaccines.

    Schmittling RJ, Archer GE, Mitchell DA, Heimberger A, Pegram C, Herndon JE 2nd, Friedman HS, Bigner DD, Sampson JH.

    J Immunol Methods. 2008 Nov 30;339(1):74-81. Epub 2008 Sep 4.PMID: 18775433 [PubMed - indexed for MEDLINE]Related articles

    29.

    Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma.

    Gururangan S, Krauser J, Watral MA, Driscoll T, Larrier N, Reardon DA, Rich JN, Quinn JA, Vredenburgh JJ, Desjardins A, McLendon RE, Fuchs H, Kurtzberg J, Friedman HS.

    Neuro Oncol. 2008 Oct;10(5):745-51. Epub 2008 Aug 28.PMID: 18755919 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.

    Maxwell JA, Johnson SP, McLendon RE, Lister DW, Horne KS, Rasheed A, Quinn JA, Ali-Osman F, Friedman AH, Modrich PL, Bigner DD, Friedman HS.

    Clin Cancer Res. 2008 Aug 1;14(15):4859-68.PMID: 18676759 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    BCNU-sequestration by metallothioneins may contribute to resistance in a medulloblastoma cell line.

    Bacolod MD, Fehdrau R, Johnson SP, Bullock NS, Bigner DD, Colvin M, Friedman HS.

    Cancer Chemother Pharmacol. 2009 Mar;63(4):753-8. Epub 2008 Jul 17.PMID: 18633619 [PubMed - indexed for MEDLINE]Related articles

    32.

    Molecular characterization of the pediatric preclinical testing panel.

    Neale G, Su X, Morton CL, Phelps D, Gorlick R, Lock RB, Reynolds CP, Maris JM, Friedman HS, Dome J, Khoury J, Triche TJ, Seeger RC, Gilbertson R, Khan J, Smith MA, Houghton PJ.

    Clin Cancer Res. 2008 Jul 15;14(14):4572-83.PMID: 18628472 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs.

    Ashley DM, Riffkin CD, Lovric MM, Mikeska T, Dobrovic A, Maxwell JA, Friedman HS, Drummond KJ, Kaye AH, Gan HK, Johns TG, Hawkins CJ.

    Br J Cancer. 2008 Jul 22;99(2):294-304. Epub 2008 Jul 1. Erratum in: Br J Cancer. 2009 Mar 24;100(6):1012. PMID: 18594532 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Colectomy and the incidence of postsurgical complications among ulcerative colitis patients with private health insurance in the United States.

    Loftus EV Jr, Delgado DJ, Friedman HS, Sandborn WJ.

    Am J Gastroenterol. 2008 Jul;103(7):1737-45. Epub 2008 Jun 28.PMID: 18564126 [PubMed - indexed for MEDLINE]Related articles

    35.

    Enterohepatic recirculation model of irinotecan (CPT-11) and metabolite pharmacokinetics in patients with glioma.

    Younis IR, Malone S, Friedman HS, Schaaf LJ, Petros WP.

    Cancer Chemother Pharmacol. 2009 Feb;63(3):517-24. Epub 2008 May 22.PMID: 18496691 [PubMed - indexed for MEDLINE]Related articles

    36.

    The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.

    Bacolod MD, Lin SM, Johnson SP, Bullock NS, Colvin M, Bigner DD, Friedman HS.

    Curr Cancer Drug Targets. 2008 May;8(3):172-9.PMID: 18473730 [PubMed - indexed for MEDLINE]Related articles

    37.

    Interstitial chemotherapy with biodegradable BCNU (Gliadel) wafers in the treatment of malignant gliomas.

    Bota DA, Desjardins A, Quinn JA, Affronti ML, Friedman HS.

    Ther Clin Risk Manag. 2007 Oct;3(5):707-15.PMID: 18472995 [PubMed - in process]Related articlesFree article

    38.

    Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.

    Everson RG, Graner MW, Gromeier M, Vredenburgh JJ, Desjardins A, Reardon DA, Friedman HS, Friedman AH, Bigner DD, Sampson JH.

    Expert Rev Anticancer Ther. 2008 May;8(5):717-32. Review.PMID: 18471045 [PubMed - indexed for MEDLINE]Related articles

    39.

    Analysis of the electrocardiographic waveforms produced by right ventricular pacing: relation to the nonpaced patterns.

    Friedman HS.

    Pacing Clin Electrophysiol. 2008 May;31(5):529-35.PMID: 18439164 [PubMed - indexed for MEDLINE]Related articles

    40.

    Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors.

    Sampson JH, Akabani G, Archer GE, Berger MS, Coleman RE, Friedman AH, Friedman HS, Greer K, Herndon JE 2nd, Kunwar S, McLendon RE, Paolino A, Petry NA, Provenzale JM, Reardon DA, Wong TZ, Zalutsky MR, Pastan I, Bigner DD.

    Neuro Oncol. 2008 Jun;10(3):320-9. Epub 2008 Apr 10.PMID: 18403491 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Safety and pharmacokinetics of dose-intensive imatinib mesylate plus temozolomide: phase 1 trial in adults with malignant glioma.

    Reardon DA, Desjardins A, Vredenburgh JJ, Sathornsumetee S, Rich JN, Quinn JA, Lagattuta TF, Egorin MJ, Gururangan S, McLendon R, Herndon JE 2nd, Friedman AH, Salvado AJ, Friedman HS.

    Neuro Oncol. 2008 Jun;10(3):330-40. Epub 2008 Mar 21.PMID: 18359865 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    A pilot study: 131I-antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost.

    Reardon DA, Zalutsky MR, Akabani G, Coleman RE, Friedman AH, Herndon JE 2nd, McLendon RE, Pegram CN, Quinn JA, Rich JN, Vredenburgh JJ, Desjardins A, Guruangan S, Boulton S, Raynor RH, Dowell JM, Wong TZ, Zhao XG, Friedman HS, Bigner DD.

    Neuro Oncol. 2008 Apr;10(2):182-9. Epub 2008 Feb 20.PMID: 18287339 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Phase I trial of VNP40101M (Cloretazine) in children with recurrent brain tumors: a pediatric brain tumor consortium study.

    Gururangan S, Turner CD, Stewart CF, O'Shaughnessy M, Kocak M, Poussaint TY, Phillips PC, Goldman S, Packer R, Pollack IF, Blaney SM, Karsten V, Gerson SL, Boyett JM, Friedman HS, Kun LE.

    Clin Cancer Res. 2008 Feb 15;14(4):1124-30.PMID: 18281546 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Tumor angiogenic and hypoxic profiles predict radiographic response and survival in malignant astrocytoma patients treated with bevacizumab and irinotecan.

    Sathornsumetee S, Cao Y, Marcello JE, Herndon JE 2nd, McLendon RE, Desjardins A, Friedman HS, Dewhirst MW, Vredenburgh JJ, Rich JN.

    J Clin Oncol. 2008 Jan 10;26(2):271-8.PMID: 18182667 [PubMed - indexed for MEDLINE]Related articles

    46.

    Clinical experience with alpha-particle emitting 211At: treatment of recurrent brain tumor patients with 211At-labeled chimeric antitenascin monoclonal antibody 81C6.

    Zalutsky MR, Reardon DA, Akabani G, Coleman RE, Friedman AH, Friedman HS, McLendon RE, Wong TZ, Bigner DD.

    J Nucl Med. 2008 Jan;49(1):30-8. Epub 2007 Dec 12.PMID: 18077533 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Medical costs and resource utilization for hemophilia patients with and without HIV or HCV infection.

    Tencer T, Friedman HS, Li-McLeod J, Johnson K.

    J Manag Care Pharm. 2007 Nov-Dec;13(9):790-8.PMID: 18062730 [PubMed - indexed for MEDLINE]Related articlesFree article

    48.

    Phase I trial of single-dose temozolomide and continuous administration of o6-benzylguanine in children with brain tumors: a pediatric brain tumor consortium report.

    Broniscer A, Gururangan S, MacDonald TJ, Goldman S, Packer RJ, Stewart CF, Wallace D, Danks MK, Friedman HS, Poussaint TY, Kun LE, Boyett JM, Gajjar A.

    Clin Cancer Res. 2007 Nov 15;13(22 Pt 1):6712-8.PMID: 18006772 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Multifocal anaplastic astrocytoma in a patient with hereditary colorectal cancer, transcobalamin II deficiency, agenesis of the corpus callosum, mental retardation, and inherited PMS2 mutation.

    Gururangan S, Frankel W, Broaddus R, Clendenning M, Senter L, McDonald M, Eastwood J, Reardon D, Vredenburgh J, Quinn J, Friedman HS.

    Neuro Oncol. 2008 Feb;10(1):93-7. Epub 2007 Nov 9.PMID: 17993636 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Screening for distress in patients with brain cancer using the NCCN's rapid screening measure.

    Keir ST, Calhoun-Eagan RD, Swartz JJ, Saleh OA, Friedman HS.

    Psychooncology. 2008 Jun;17(6):621-5.PMID: 17973236 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...